These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16623947)

  • 1. A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study.
    Asselbergs FW; Moore JH; van den Berg MP; Rimm EB; de Boer RA; Dullaart RP; Navis G; van Gilst WH
    BMC Med Genet; 2006 Apr; 7():39. PubMed ID: 16623947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the correlation between CETP TaqIB, KCNE1 S38G and eNOS T-786C gene polymorphisms for predisposition and non-valvular atrial fibrillation].
    Xu LX; Yang WY; Zhang HQ; Tao ZH; Duan CC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 May; 29(5):486-92. PubMed ID: 18956684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of CETP and CRP gene polymorphisms with non-valvular atrial fibrillation in Chinese Han population].
    Yang WY; Xu LX; Zhang HQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):225-9. PubMed ID: 18393253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism.
    Lu H; Inazu A; Moriyama Y; Higashikata T; Kawashiri MA; Yu W; Huang Z; Okamura T; Mabuchi H
    J Mol Med (Berl); 2003 Apr; 81(4):246-55. PubMed ID: 12700892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
    Le Goff W; Guerin M; Nicaud V; Dachet C; Luc G; Arveiler D; Ruidavets JB; Evans A; Kee F; Morrison C; Chapman MJ; Thillet J
    Atherosclerosis; 2002 Apr; 161(2):269-79. PubMed ID: 11888509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of APOE and CETP TaqIB Polymorphisms with Type 2 Diabetes Mellitus.
    Srirojnopkun C; Kietrungwilaikul K; Boonsong K; Thongpoonkaew J; Jeenduang N
    Arch Med Res; 2018 Oct; 49(7):479-485. PubMed ID: 30853126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
    de Grooth GJ; Zerba KE; Huang SP; Tsuchihashi Z; Kirchgessner T; Belder R; Vishnupad P; Hu B; Klerkx AH; Zwinderman AH; Jukema JW; Sacks FM; Kastelein JJ; Kuivenhoven JA
    J Am Coll Cardiol; 2004 Mar; 43(5):854-7. PubMed ID: 14998629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.
    Weitgasser R; Galvan G; Malaimare L; Derflinger I; Hedegger M; Lang J; Iglseder B; Ladurner G; Paulweber B
    Biomed Pharmacother; 2004 Dec; 58(10):619-27. PubMed ID: 15589073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM; Sacks FM; Jukema JW; Shepherd J; Freeman DJ; McMahon AD; Cambien F; Nicaud V; de Grooth GJ; Talmud PJ; Humphries SE; Miller GJ; Eiriksdottir G; Gudnason V; Kauma H; Kakko S; Savolainen MJ; Arca M; Montali A; Liu S; Lanz HJ; Zwinderman AH; Kuivenhoven JA; Kastelein JJ
    Circulation; 2005 Jan; 111(3):278-87. PubMed ID: 15655129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CETP TaqIB Polymorphism, Serum Lipid Levels And Risk Of Atrial Fibrillation: A Case-Control Study.
    Galati F; Colonna P; Galati A; Ciardiello C; Bozzetti MP; Massari S
    J Atr Fibrillation; 2014; 6(6):964. PubMed ID: 27957053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population.
    Corella D; Sáiz C; Guillén M; Portolés O; Mulet F; González JI; Ordovás JM
    Atherosclerosis; 2000 Oct; 152(2):367-76. PubMed ID: 10998464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group.
    Gudnason V; Kakko S; Nicaud V; Savolainen MJ; Kesäniemi YA; Tahvanainen E; Humphries S
    Eur J Clin Invest; 1999 Feb; 29(2):116-28. PubMed ID: 10092998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence-based detection of the CETP TaqIB polymorphism: false positives with the TaqMan-based exonuclease assay attributable to a previously unknown gene variant.
    Teupser D; Rupprecht W; Lohse P; Thiery J
    Clin Chem; 2001 May; 47(5):852-7. PubMed ID: 11325888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men.
    Eiriksdottir G; Bolla MK; Thorsson B; Sigurdsson G; Humphries SE; Gudnason V
    Atherosclerosis; 2001 Nov; 159(1):187-92. PubMed ID: 11689220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis.
    Arca M; Montali A; Ombres D; Battiloro E; Campagna F; Ricci G; Verna R
    Clin Genet; 2001 Nov; 60(5):374-80. PubMed ID: 11903340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C-->A polymorphism and a novel promoter variant are independently associated with CETP concentration.
    Klerkx AH; Tanck MW; Kastelein JJ; Molhuizen HO; Jukema JW; Zwinderman AH; Kuivenhoven JA
    Hum Mol Genet; 2003 Jan; 12(2):111-23. PubMed ID: 12499392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Bakker SJ; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4198-204. PubMed ID: 15840744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
    Liu S; Schmitz C; Stampfer MJ; Sacks F; Hennekens CH; Lindpaintner K; Ridker PM
    Atherosclerosis; 2002 Apr; 161(2):469-74. PubMed ID: 11888533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the distribution and association of cholesteryl ester transfer protein-TaqIB polymorphism and plasma concentration in general population].
    Liu J; Zhao D; Liu S; Liu J; Qin LP; Wu ZS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):300-3. PubMed ID: 12820950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.